JP2023530379A5 - - Google Patents
Info
- Publication number
- JP2023530379A5 JP2023530379A5 JP2022547232A JP2022547232A JP2023530379A5 JP 2023530379 A5 JP2023530379 A5 JP 2023530379A5 JP 2022547232 A JP2022547232 A JP 2022547232A JP 2022547232 A JP2022547232 A JP 2022547232A JP 2023530379 A5 JP2023530379 A5 JP 2023530379A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleic acid
- rna
- acid molecule
- circrna
- molecule according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062969758P | 2020-02-04 | 2020-02-04 | |
| US62/969,758 | 2020-02-04 | ||
| PCT/US2021/025463 WO2021159129A2 (en) | 2020-02-04 | 2021-04-01 | Compositions and methods for circular rna expression |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023530379A JP2023530379A (ja) | 2023-07-18 |
| JP2023530379A5 true JP2023530379A5 (https=) | 2024-04-08 |
Family
ID=77199626
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022547232A Pending JP2023530379A (ja) | 2020-02-04 | 2021-04-01 | 環状ｒｎａ発現のための組成物および方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US12600987B2 (https=) |
| EP (1) | EP4100523A4 (https=) |
| JP (1) | JP2023530379A (https=) |
| AU (1) | AU2021216593A1 (https=) |
| CA (1) | CA3168840A1 (https=) |
| WO (1) | WO2021159129A2 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2024003262A (es) | 2021-09-17 | 2024-06-19 | Flagship Pioneering Innovations Vi Llc | Composiciones y metodos para producir poliribonucleotidos circulares. |
| JP2026500226A (ja) * | 2022-12-07 | 2026-01-06 | サーキヨ・アクチエボラグ | ｃｉｒｃＲＮＡ発現コンストラクト |
| CN121241137A (zh) * | 2023-05-24 | 2025-12-30 | 南京金斯瑞生物科技有限公司 | 用于制备环状rna的载体和方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ITRM20020253A1 (it) | 2002-05-08 | 2003-11-10 | Univ Roma | Molecole chimeriche di snrna con sequenze antisenso per le giunzioni di splicing del gene della distrofina e applicazioni terapeutiche. |
| FR2874384B1 (fr) | 2004-08-17 | 2010-07-30 | Genethon | Vecteur viral adeno-associe pour realiser du saut d'exons dans un gene codant une proteine a domaines dispensables |
| CN107447033B (zh) | 2017-09-15 | 2020-11-17 | 东南大学 | 一种结直肠癌诊断生物标志物及其应用 |
| JP7385282B2 (ja) * | 2017-11-07 | 2023-11-22 | ザ・ユニヴァーシティ・オヴ・ノース・キャロライナ・アト・チャペル・ヒル | 環状ｒｎａ分子のための方法及び組成物 |
-
2021
- 2021-04-01 AU AU2021216593A patent/AU2021216593A1/en active Pending
- 2021-04-01 WO PCT/US2021/025463 patent/WO2021159129A2/en not_active Ceased
- 2021-04-01 JP JP2022547232A patent/JP2023530379A/ja active Pending
- 2021-04-01 US US17/796,874 patent/US12600987B2/en active Active
- 2021-04-01 CA CA3168840A patent/CA3168840A1/en active Pending
- 2021-04-01 EP EP21750796.1A patent/EP4100523A4/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022544412A5 (https=) | ||
| US9458459B2 (en) | Methods for enhancing utrophin production via inhibition of microRNA | |
| AU2013248981B2 (en) | Mirna modulators of thermogenesis | |
| JP2023530379A5 (https=) | ||
| CN104583400A (zh) | 用于调节pten表达的组合物和方法 | |
| CN104602714A (zh) | 用于调节bdnf表达的组合物和方法 | |
| CN104582737A (zh) | 用于调节apoa1和abca1表达的组合物和方法 | |
| JP2025524740A (ja) | オリゴヌクレオチド送達増強剤、医薬組成物およびそれらを使用する方法 | |
| WO2019204451A1 (en) | Enhanced lipid nanoparticle drug delivery using a negatively charged polymer | |
| CN111918968A (zh) | Micro-RNA 22的抑制剂 | |
| JP2023506546A (ja) | Ｂ型肝炎ウイルス感染症を処置するためのｓｅｐｔ９阻害剤の使用 | |
| WO2022206739A1 (zh) | 一种基于病毒载体的rna递送系统及其应用 | |
| EP4269585A1 (en) | Guide rna for editing polyadenylation signal sequence of target rna | |
| JP2023506540A (ja) | Ｂ型肝炎ウイルス感染を処置するためのｓｃａｍｐ３阻害剤の使用 | |
| EP4265724A1 (en) | Rnai agent for inhibiting hbv expression and use thereof | |
| KR101168726B1 (ko) | 암 치료용 약학 조성물 | |
| JP2025094072A (ja) | Ｂ型肝炎ウイルス感染を処置するためのｃｏｐｓ３阻害剤の使用 | |
| WO2024002045A1 (en) | Oligonucleotide delivery agents, pharmaceutical compositions and methods using the same | |
| Riasi et al. | Effect of Intramuscular and Intraperitoneal Injections of conjugated MSTN-siRNA-cholesterol on Inhibition of Myostatin Gene expression. | |
| AU2020349991A1 (en) | Nucleic acid molecule for treating immune thrombocytopenia and application thereof | |
| JP2023506954A (ja) | Ｂ型肝炎ウイルス感染を処置するためのｓａｒａｆ阻害剤の使用 | |
| CN118202046A (zh) | 具有降低的脱靶效应的经修饰的小干扰rna分子 | |
| WO2022206778A1 (zh) | 一种用于治疗肺纤维化的rna质粒递送系统 | |
| WO2022206784A1 (zh) | 一种用于治疗肺纤维化的rna递送系统 | |
| JP2023506550A (ja) | Ｂ型肝炎ウイルス感染症を処置するためのｓｂｄｓ阻害剤の使用 |